Updated on 1 October 2014
Dementia sufferers in Korea will cross one million mark by 2024
Singapore: France-based Mensia Technologies has announced its collaboration with Korea-based Y brain, which is currently developing the world's first EEG-driven treatment option for patients with brain diseases.
Mensia technologies offers advanced software solutions for neurophysiology, including a 3-D visualized display of one's brain activity in real-time.
Ybrian is developing a wearable device for Alzheimer's disease. The device is currently under clinical trials and is scheduled to be released in South Korea early next year.
Mr Yun Kyong-sik, CEO, Ybrain, said, "The French company's technology, which allows an individual to monitor brain activity as well as stress levels on their own in real-time, is extremely useful for their current project."
Mr Kyong-sik said that in collaboration with Menisa Technologies, Ybrain will be able to develop a technology that can monitor the future condition of the brain.